Iotrolan

Iotrolan
Systematic (IUPAC) name
	2,4,6-triiodo-5-{N-methyl-2-[methyl({2,4,6-triiodo-3,5-bis[(1,3,4-trihydroxybutan-2-yl)carbamoyl]phenyl})carbamoyl]acetamido}-1-N,3-N-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide
Clinical data
AHFS/Drugs.com	International Drug Names
Pregnancy; category	Contraindicated;
Legal status	℞ (Prescription only);
Identifiers
CAS Number	79770-24-4
ATC code	V08AB06 (WHO)
PubChem	CID: 3738
UNII	16FL47B687
KEGG	D01714
ChEMBL	CHEMBL1200555
Chemical data
Formula	C37H48I6N6O18
Molecular mass	1626.23 g/mol
(what is this?) (verify)

Lua error in package.lua at line 80: module 'strict' not found.

Iotrolan (trade name Isovist) is a radiocontrast agent, a substance used to improve the visibility of body structures on images obtained by X-ray techniques. It is particularly used to image spaces surrounding the central nervous system, such as the ventricles, after injection into the cerebrospinal fluid.^[1] It can also be used to image joint spaces and in endoscopic retrograde cholangiopancreatography (ERCP).^{[citation needed]}

Chemically, the substance is a dimer of triiodinated isophthalic acid derivatives.

References

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.